Search

everythinglearnresearchcommunity

for

Search:↓

We now understand more about what causes acne and this could lead to better, more personalized treatments.

PCOS is influenced by various factors and may be managed by restoring gut health and using new therapies.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Nanocarriers can make acne treatments more effective and gentle on the skin.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Smaller particles of the drug carrier penetrated skin better, with 300 nm size being best for targeting hair follicles.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.